XCOVERY HOLDING CO LLC has a total of 46 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NEUROSEARCH SWEDEN AB, RIVUS PHARMACEUTICALS INC and LEIBNIZ INST FOR NATURAL PRODU.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Canada | 7 | |
#3 | Australia | 5 | |
#4 | Republic of Korea | 5 | |
#5 | United States | 5 | |
#6 | Brazil | 4 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | China | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 2 | |
#10 | Japan | 2 | |
#11 | Israel | 1 | |
#12 | Mexico | 1 | |
#13 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Liang Congxin | 44 |
#2 | Li Zhigang | 11 |
#3 | Li Zhi-Gang | 3 |
#4 | Lin Zhigang | 2 |
#5 | Llang Congxin | 1 |
Publication | Filing date | Title |
---|---|---|
EA025030B1 | Compound {5-[(1r)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-6-aminopyridazin-3-yl}-n-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)carboxamide as kinase inhibitor | |
EP2625176A2 | Substitututed 6-amino-pyridazin-3-yl-carboxamide compounds as protein kinase modulators | |
KR20130113950A | Mtor selective kinase inhibitors | |
EP2483272A2 | Pi3k (delta) selective inhibitors | |
EP2382207A2 | Pi3k/mtor kinase inhibitors | |
AU2009269087A1 | PI3K isoform selective inhibitors | |
BRPI0914305A2 | Substituted carboxamide pyridazine compounds as kinase inhibitor compounds |